Quinn Emanuel’s life sciences partners represent pharmaceutical, biotechnology, medical device, and other life sciences companies from around the world.  Our life sciences  practice is based on an inter-disciplinary model that allows us to become fully familiar with our clients’ businesses and to represent our clients in a wide variety of disputes, including: 

     • Intellectual Property
     • Product Liability
     • Government Investigations
     • Off-label promotion, and
     • Appeals in all subject matters.

Our lawyers know the science.  More than 140 of us have degrees in virtually all engineering disciplines and in sciences such as physics, chemistry, pharmacology, molecular biology, biochemistry, and chemical engineering.

We combine this scientific knowledge with first-quality trial skills, making complex subject matter understandable to lay courts and juries.   We have a deep bench of highly successful first-chair trial lawyers who work extensively on pharmaceutical and biotechnology patent cases, and other partners with substantial (and successful) experience in product liability cases.

We have won jury verdicts and summary judgment for our life sciences clients at the trial court level.  And we have defended these results before appellate courts, including the Federal Circuit and the United States Supreme Court.  We have also represented companies before the United States International Trade Commission, arbitration panels, and foreign tribunals. 

Our lawyers also have significant experience in cross-border disputes.  Many major patent disputes involve lawsuits in both the U.S. and the EU, and over 80% of the patent suits in the EU are filed in Germany.  We have German offices in Munich, Hamburg, and Mannheim; each of these offices focuses on intellectual property.  Our German and U.S. lawyers work seamlessly to provide our clients with better service, and at a lower price, than would be the case if two firms were involved. In 2016, JUVE, the leading German legal periodical, named our German offices both “IP Firm of the Year” and “Patent Litigation Firm of the Year.” Our U.S. intellectual property group has won similar accolades from other leading publications such as The American Lawyer (2012), Benchmark Litigation (2011-207), and Law360 (2010-2017).   

Our lawyers recognize the best result is often a negotiated resolution.  While we are a firm of trial lawyers, we recognize that many cases are best served by an early resolution procedure like summary judgment or by vigorous preparation for trial leading to a favorable settlement. 

sticky image